Curasight Competitors and Similar CompaniesClear all
Curasight's competitors and similar companies include CIRS, Blue Earth Diagnostics and Microvascular Therapeutics.
 Curasight Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). |  CIRS CIRS (also known as Computerized Imaging Reference Systems) is a company that manufactures tissue equivalent phantoms and simulators intended to improve upon existing tissue simulation methodology. |  Microvascular Therapeutics Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100. | ||
Founding Date | Founding Date 2013 | Founding Date 1982 | Founding Date 2014 | Founding Date 2016 |
Type | Type Private | Type Private | Type Subsidiary | Type Private |
Tags | ||||
Locations | Locations København, DK HQ | Locations Norfolk, US HQ | Locations Oxford, GB HQ Dublin, IE Burlington, US | Locations Tucson, US HQ |
Employees | Employees 7 | Employees 254% decrease | Employees 1061% decrease | Employees 1220% increase |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 19.7m | Total funding raised $ 1.6m |
For sources of this data, please see the company profile
View Company Profiles
CIRS
HQ
Norfolk, US
Employees
25↓ 4% decrease
CIRS (also known as Computerized Imaging Reference Systems) is a company that manufactures tissue equivalent phantoms and simulators intended to improve upon existing tissue simulation methodology.
View company
Blue Earth Diagnostics
HQ
Oxford, GB
Blue Earth Diagnostics is a molecular imaging diagnostics company.
View companyMicrovascular Therapeutics
HQ
Tucson, US
Employees
12↑ 20% increase
Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100.
View company